Mechanism of Action of Recombinant Activated Factor VII: An Update
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 43, S105-S107
- https://doi.org/10.1053/j.seminhematol.2005.11.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Clinical experience with recombinant factor VIIaBlood Coagulation & Fibrinolysis, 1998
- Prospective, Randomised Trial of Two Doses of rFVIIa (NovoSeven) in Haemophilia Patients with Inhibitors Undergoing SurgeryThrombosis and Haemostasis, 1998
- Transmission of a procoagulant signal from tissue factor-bearing cells to plateletsBlood Coagulation & Fibrinolysis, 1996
- Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsBlood Coagulation & Fibrinolysis, 1995
- Initiation and regulation of tissue factor-dependent blood coagulation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Factor VIIa in the treatment of haemophiliaBlood Coagulation & Fibrinolysis, 1990
- Native fibrin gel networks observed by 3D microscopy, permeation and turbidityBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIBlood, 1983
- Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.Journal of Clinical Investigation, 1983
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981